Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-11-01
著者
-
Matsudaira Ran
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Takasaki Yoshinari
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
YAMAJI Ken
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
Yamaji Ken
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Tamura Naoto
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Matsushita Masakazu
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Kon Takayuki
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Sugimoto Kaoru
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Kusaoi Makio
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
Ogasawara Michihiro
Department Of Internal Medicine And Rheumatology Juntendo University School Of Medicine
-
ONUMA Shin
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
KAGEYAMA Michiaki
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
SEKIYA Fumio
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
TADA Kurisu
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
KEMPE Kazuo
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
KON Takayuki
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine
-
Takasaki Yoshinari
Department of Internal Medicine and Rheumatology
-
Takasaki Yoshinari
Department of Internal Medicine
関連論文
- Activated peripheral blood mononuclear cells detected in lupus patients using cDNA coding for proliferating cell nuclear antigen
- Successful treatment of severe Reiter's Syndrome with etretinate
- Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients
- Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits
- Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population
- Multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus
- Decrease in CD4^+CD25^+ and CD8^+CD28^+ T cells in interstitial pneumonitis associated with rheumatic disease
- Cavitary lung lesion in a patient with systemic lupus erythematosus : an unusual manifestation of cytomegalovirus pneumonitis
- Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus
- Long-term prognosis in lupus nephritis: relation to the renal biopsy data, therapy, and grade of remission
- Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease
- Anti-Ki antibodies recognize an epitope homologous with SV40 nuclear localization signal : clinical signifficance and reactivities in various immunoassays
- Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosus
- Scleredema : report of a case
- Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjogren's syndrome : a double-blind placebo-controlled multicenter trial
- Endothelial cell-binding antibodies in patients with systemic lupus erythematosus
- A case of intestinal Behcet's disease in association with HLA-B27 and HLA-B51
- Cyclosporin A therapy for interstitial pneumonitis associated with rheumatic disease
- A case of mixed connective tissue disease associated with macrovascular lesions in the upper and lower extremities
- A case of very-late-onset systemic lupus erythematosus
- Anti-proteasome activator 28α is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjogren's syndrome
- CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus
- CD154 expression and mRNA stability of activated CD4-positive T cells in patients with systemic lupus erythematosus
- Pentoxifylline induces the shedding of L-selectin on polymorphonuclear cells by stimulation via adenosine receptor as well as by the inhibition of phosphodiesterase
- Sjogren syndrome associated with multiple myeloma of the lgA _k-type
- A case of inclusion body myositis with systemic sclerosis
- Analysis of autoantibodies to cell cycle-assosiated antigens
- Cyclosporine treatment of advanced interstitial pneumonitis associated with systemic sclerosis
- 2-2). The Expression of LFA-1, ICAM-1, CD80 and CD86 Molecules in Lupus Patiens : Implication for Immunotherapy
- Relation between the levels of soluble CD4, CD8 and CD23 molecules in sera and clinical manifestations and laboratory data in patients with systemic lupus erythematosus
- Current topics on therapeutic apheresis
- A CELL CYCLE REGULATOR, XBtg2 IS REQUIRED FOR XENOPUS NEURAL DEVELOPMENT(Developmental Biology,Abstracts of papers presented at the 76^ Annual Meeting of the Zoological Society of Japan)
- Central nervous system involvements of patients with systemic lupus erythematosus
- Clinical significance of antibodies to PCNA
- 実験動物科学における野生マウスの利用 野生由来マウス系統を用いた行動遺伝学の新展開
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
- Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis
- Regenerating gene (REG) 1 alpha promotes pannus progression in patients with rheumatoid arthritis
- Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population
- Rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab
- The Long-Term Prognosis of Lupus Nephritis Patients Treated with Intravenous Cyclophosphamide
- Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan
- Follow Up Study on the Changes in the Clinical Features and Prognosis of Japanese Patients with Systemic Lupus Erythematosus During the Past 3 to 4 Decades
- Two Cases of Refractory Wegeners Granulomatosis Successfully Treated with Rituximab
- Evaluation of New Immunoadsorbent CF-X from the Viewpoint of Pathogenic Factor Adsorptive Performance(New Adsorbent and Technical Development,General Presentation)
- Retrospective Study in Peripheral Blood Stem Cell Harvest(Symposium 1: Stem Cell Harvest)
- Clinical Evaluation and the Appropriate Treatment for DFPP in Familial Hypercholesterolemia (FH)(LDL-Apheresis)